chantal decroisette

A huge thank you to everyone for your kind words, warm messages and congratulations following the presentation of PERSEE at #ESMO26! ❤️

An incredible team effort after 7 years of hard work, dedication and perseverance.

So happy and proud to share this moment with you all! 🙏✨

PERSEE, GFPC academic phase III trial meets its primary endpoint!
In 1L advanced NSCLC with PD-L1 ≥50%, pembrolizumab + chemotherapy significantly improved PFS vs pembrolizumab alone:
16.1 vs 6.9 months; HR 0.56; p<0.001.

📍 Join us at #ESMO26 !! cslide.ctimeetingtech.com/esmo2026/atten…

Very honored to present the results of the PERSEE phase III trial (GFPC 01-2020) in an oral session at #ESMO26 in Madrid 🇪🇸

📅 Sunday, October 25
🕙 10:15 AM
🎤 Abstract 2614O
cslide.ctimeetingtech.com/esmo2026/atten…
Thank you to the investigators, the GFPC, Brest CHU and Centre Leon Bérard !

Merci à tous !!!

Merci aux médecins , sponsors , ARC d’avoir insufflé autant de convivialité à la Réunion Plénière du @myGFPC à St Étienne. Merci à tous pour les projets scientifiques ( @FGuisier @Bylicki2 …)Félicitations à Laurent @LGreillier, nouveau président ! Merci à @cchouaid pour tout 😊